| 澳大利亚经验对我国药品价格管制的启示 |
| |
| 引用本文： | 龚向光,胡善联.澳大利亚经验对我国药品价格管制的启示[J].中国卫生经济,2002,21(11):47-50. |
| |
| 作者姓名： | 龚向光 胡善联 |
| |
| 作者单位： | 复旦大学医学院,上海市,200032 |
| |
| 摘 要： | 通过药品管理体系、定价方法、通用品替代政策和药品价格管制对医药行业的影响等方面，对澳大利亚药品价格管制经验作了详细的介绍，并从中得出中国目前在药品价格管制改革过程中注意的问题。
|
| 关 键 词： | 中国 经验借鉴 药品定价方式 澳大利亚 药品价格管制 |
| 文章编号： | 1003-0743(2002)11-0047-04 |
| 修稿时间： | 2002年4月2日 |
Impression of Australian Experience to Chinese Drug Pricing Regulation |
| |
| Gong Xiangguang,HU Shanlian.Impression of Australian Experience to Chinese Drug Pricing Regulation[J].Chinese Health Economics,2002,21(11):47-50. |
| |
| Authors: | Gong Xiangguang HU Shanlian |
| |
| Abstract: | The authors introduced the experience of Australian drug pricing regulation, including the regulation system, the pricing method, the generic substitution policy, and the implication of pricing regulation to pharmaceutical industry. Through the experience of Australian, the authors concluded that some issues should be considered during the drug precing regulation reform in China. |
| |
| Keywords: | drug pricing hegulation |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
